

Product Information
Name:(R)-(-)-N-(3,5-Dinitrobenzoyl)-a-phenylglycine
Brand:Biosynth
Description:(R)-(-)-N-(3,5-Dinitrobenzoyl)-a-phenylglycine ((R)-DBBG) is a chiral molecule that is used as an anthelmintic drug. It is a derivative of the amino acid glycine and has been shown to inhibit angiogenesis in cancerous tumors. (R)-DBBG inhibits fatty acid synthesis by binding to the acyl carrier protein and inhibiting the conversion of acetate to malonyl coenzyme A. This inhibition leads to a depletion of long-chain fatty acids, which can be detected by chromatography. The enantiomers have been shown to have different effects on rat liver microsomes, with one enantiomer being more potent than the other. The kinetic studies show that the amines react with R-DBBG and form an intermediate with a reactive α1-acid glycoprotein, which subsequently reacts with hydrogen peroxide and forms a reactive intermediate that decom
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:345.26 g/mol
Formula:C15H11N3O7
Purity:Min. 95%